CP and ovarian cancer: The 3D spheroid model mimics the in vivo growth of ovarian cancer cells in the peritoneum [30,31], and therefore it was chosen for testing the ability of RV, CP and GANT61 to limit the pro-tumorigenic activity of LPA in terms of cancer cell growth and responsiveness to standard drug treatment.